晚期或转移性黑色素瘤的临床试验
总计2490个结果
-
Agenus Inc.暂停
-
Lytix Biopharma ASLaboratory Corporation of America; OWL主动,不招人
-
Peking University Cancer Hospital & Institute未知
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.; Simcere Zaiming招聘中
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany招聘中
-
Pierre Fabre Medicament招聘中
-
Grupo Español Multidisciplinar de Melanoma招聘中
-
PrimeVax Immuno-Oncology Inc.Walter Reed Army Institute of Research (WRAIR)尚未招聘晚期黑色素瘤
-
Abramson Cancer Center at Penn MedicineNovartis Pharmaceuticals终止
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC撤销
-
Dr. Ronnie Shapira尚未招聘转移性黑色素瘤 | 恶性黑色素瘤 | 免疫疗法 | 恶性黑色素瘤 IV 期 | BRAF V600E
-
Centre Hospitalier Universitaire de Nice招聘中
-
Centre Hospitalier Universitaire Vaudois主动,不招人
-
Providence Health & ServicesPrometheus Laboratories主动,不招人
-
H. Lee Moffitt Cancer Center and Research Institute主动,不招人
-
The Netherlands Cancer InstituteCopenhagen University Hospital at Herlev主动,不招人
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.主动,不招人
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLC终止
-
Iovance Biotherapeutics, Inc.主动,不招人
-
Novartis Pharmaceuticals终止
-
F. Stephen Hodi, MDMedImmune LLC完全的
-
The Christie NHS Foundation TrustNational Institute for Health Research, United Kingdom终止
-
Biocad主动,不招人黑色素瘤 | 黑色素瘤转移俄罗斯联邦, 白俄罗斯
-
Netherlands Working Group on Immunotherapy of OncologyHoffmann-La Roche; Amsterdam UMC, location VUmc; The Netherlands Cancer Institute终止
-
Nektar TherapeuticsImaginAb, Inc.撤销
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer Institute撤销
-
BioNTech US Inc.Apexigen, Inc.终止